Individual specific variable drug response against similar drugs raises a significant
challenge for the effective and safe treatment of many human diseases. Pharmacogenomics …

Aim: To develop and assess an augmented reality tool for pharmacogenomics (PGx)
education based on artificial intelligence. Materials & methods: A HoloLens application was …

Purpose: Adverse drug reactions such as ototoxicity, which occurs in approximately one-fifth
of adult patients who receive cisplatin treatment, can incur large socioeconomic burdens on …

The current excitement for affordable genomics technologies and national precision
medicine initiatives marks a turning point in worldwide healthcare practices. The last decade …

The increasing availability of next generation sequencing (NGS) for personal genomics
could promote pharmacogenomics (PGx) discovery and application. However, current tools …

Drug development is a long and costly process, often limited by the toxicity and adverse
drug reactions (ADRs) caused by drug candidates. Even on the market, some drugs can …

One of the challenges that arise from the advent of personal genomics services is to
efficiently couple individual data with state of the art Pharmacogenomics (PGx) knowledge …

We present g-Nomic, a pharmacogenetics interpretation software that analyzes globally a
prescribed medication taking into account the personal background genetics, drug–drug …

Objective The objective of this meta‐analysis is to evaluate the impact of genetic
polymorphisms on platinum‐based chemotherapy (PBC)‐induced ototoxicity. Data Sources …

Coumarins are widely prescribed worldwide, and in Mexico acenocumarol is the preferred
form. It is well known that despite its efficacy, coumarins show a high variability for dose …